ANA-话题@MedSci

#ANA#

386篇内容 | 2261人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1633281, encodeId=fe7b1633281e7, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=FDA批准阿伐那非（Avanafil）治疗男性勃起功能障碍, objectType=article, longId=6014, objectId=90f1601484, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90f1601484, replyNumber=0, likeNumber=81, createdTime=2013-04-08, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90f1601484, moduleTitle=FDA批准阿伐那非（Avanafil）治疗男性勃起功能障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90f1601484)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633282, encodeId=b5f716332828f, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=Analy Chem：适合发展中国家的新型廉价纸基糖尿病测试, objectType=article, longId=6517, objectId=777b651e6d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=777b651e6d, replyNumber=0, likeNumber=67, createdTime=2012-08-21, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=777b651e6d, moduleTitle=Analy Chem：适合发展中国家的新型廉价纸基糖尿病测试, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=777b651e6d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633278, encodeId=0b6916332e894, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=Incidence of primary sclerosing cholangitis: a systematic review and meta-analys, objectType=article, longId=2734, objectId=ead82e3453, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ead82e3453, replyNumber=0, likeNumber=73, createdTime=2011-11-24, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ead82e3453, moduleTitle=Incidence of primary sclerosing cholangitis: a systematic review and meta-analys, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ead82e3453)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633279, encodeId=435816332e9ac, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=Nuclear receptors as new perspective for the management of liver diseases, objectType=article, longId=2743, objectId=36832e435d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36832e435d, replyNumber=0, likeNumber=56, createdTime=2011-12-08, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36832e435d, moduleTitle=Nuclear receptors as new perspective for the management of liver diseases, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36832e435d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633276, encodeId=190a16332e661, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=试验方法提交指南Guidelines For The Submission Of Protocol Of Analysis, objectType=article, longId=425, objectId=a691425cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a691425cf, replyNumber=0, likeNumber=67, createdTime=2010-11-27, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a691425cf, moduleTitle=试验方法提交指南Guidelines For The Submission Of Protocol Of Analysis, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a691425cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633277, encodeId=f4a816332e7f8, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=Review Manager(RevMan)4.2软件教程（中文版）及软件下载, objectType=article, longId=563, objectId=e374563f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e374563f5, replyNumber=0, likeNumber=75, createdTime=2010-11-21, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e374563f5, moduleTitle=Review Manager(RevMan)4.2软件教程（中文版）及软件下载, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e374563f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ANA

2020-05-29

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

FDA批准阿伐那非（Avanafil）治疗男性勃起功能障碍

2013-04-08

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

Analy Chem：适合发展中国家的新型廉价纸基糖尿病测试

2012-08-21

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

Incidence of primary sclerosing cholangitis: a systematic review and meta-analys

2011-11-24

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

Nuclear receptors as new perspective for the management of liver diseases

2011-12-08

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

试验方法提交指南Guidelines For The Submission Of Protocol Of Analysis

2010-11-27

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

Review Manager(RevMan)4.2软件教程（中文版）及软件下载

2010-11-21

科室
- - 订阅+
  - 更多科室
工具
服务